Q3 FY26: 10.6% revenue growth, Rs 3.5 interim dividend declared
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Smallcap 250 and 0.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q3 FY26 results. Consolidated revenue Rs 6,598M, up 10.6% YoY. Nine month revenue up 10.8% at Rs 20,602M. Q3 PAT Rs 914M, down 6.8% YoY due to Rs 301M exceptional Labour Code charge; 9M PAT up 12.1% at Rs 3,776M. Third interim dividend of Rs 3.5 per share declared (record date Feb 5). Total dividends Rs 16.5 per share this year. Also allotted 4,000 ESOP shares.
Steady revenue growth and consistent dividends reward shareholders. One-time Labour Code charge weighed on Q3 profit.